Larvol Delta - Clinical-Trial-to-Evaluate-the-Safety-and-Efficacy-of-IM21-CART-Cells-in-Patients-With-Relapsed-and-Refractory-RR-Multiple-Myeloma

IM21 CART - Immunochina Pharma

http://clinicaltrials.gov/ct2/show/NCT05478343

Jul 28, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next